ClinicalTrials.gg
CompletedNCT07106866Updated Aug 6, 2025

LOOP VS DOUBLE SUTURE TECHNIQUES IN SACROSPINOUS FIXATION: A TWO-YEAR STUDY

An observational study in Pelvic Organ Prolapse and Surgical Procedure; Complications, Late Effect of Complications, sponsored by Zeynep Kamil Maternity and Pediatric Research and Training Hospital. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 30 Years to 80 Years. Per ClinicalTrials.gov, last updated 2025-08-06.

Sponsored by Zeynep Kamil Maternity and Pediatric Research and Training Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
195
Ages
30 Years to 80 Years
Sex
Female
01

Study summary

This retrospective cohort study aimed to compare clinical outcomes between the classical double suture technique and a modified loop suture technique used in sacrospinous ligament fixation for stage 3 or 4 pelvic organ prolapse. A total of 195 patients underwent surgery at a tertiary care center between January 2020 and January 2023. The primary outcome was the rate of reoperation due to recurrence within 24 months. Secondary outcomes included operative time, prolapse recurrence rate, and postoperative complications such as gluteal pain. The study was designed to evaluate whether a simplified suture method could improve surgical efficiency and patient recovery without compromising anatomical success.

Read the detailed description

Sacrospinous ligament fixation is a commonly used surgical procedure for apical pelvic organ prolapse, particularly in women with advanced-stage prolapse who desire a native tissue repair approach. With increasing concerns regarding mesh-related complications, sacrospinous fixation has regained popularity as a mesh-free alternative.

This retrospective cohort study was conducted to evaluate and compare the clinical performance of two different suture techniques: the classical double suture method and a modified loop suture method. The main objective was to assess whether the loop suture technique, which involves a single point of tension, offers advantages in terms of operative efficiency and patient outcomes.

A total of 195 patients with stage 3 or 4 pelvic organ prolapse underwent sacrospinous ligament fixation between January 2020 and January 2023 at a tertiary urogynecology center. One group received the standard double suture technique, while the other underwent fixation using a single loop suture. All surgeries were performed by the same experienced surgical team.

The primary outcome was reoperation rate due to recurrence within 24 months. Secondary outcomes included total operative time, recurrence rate (as defined by POP-Q stage ≥2), and postoperative complications such as gluteal pain and rectal injury.

This study aims to provide evidence on whether a technical modification in a widely accepted native tissue repair procedure can improve surgical safety and reduce long-term complication rates.

02

Conditions studied

  • Pelvic Organ Prolapse
  • Surgical Procedure; Complications, Late Effect of Complications

Browse trials for

Keywords

  • urogynecology
  • pelvic organ prolapse
  • sacrospinous ligament fixation
  • prolapse recurrence
03

In context

Pelvic Organ Prolapse

521 studies on the registry are indexed under Pelvic Organ Prolapse; 80 are open to participants now.

This study's enrollment of 195 is above the median of 134 across 171 observational studies indexed under Pelvic Organ Prolapse.

Browse Pelvic Organ Prolapse studies →

Lead sponsor

Zeynep Kamil Maternity and Pediatric Research and Training Hospital is the lead sponsor of 38 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years to 80 Years
Sexes eligible
Female
Sampling method
Non-probability sample

Study population

Women aged 30 to 80 years with stage 3 or 4 apical pelvic organ prolapse who underwent sacrospinous ligament fixation at a tertiary urogynecology center. All patients were treated between January 2020 and January 2023.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Stage 3 or 4 apical pelvic organ prolapse
  • Underwent SSF between Jan 2020 and Jan 2023

Exclusion criteria

Exclusion Criteria:

  • Concomitant
  • Previous apical prolapse surgery
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
195 participants (actual)
Patient registry
No

Groups and cohorts

  • Double Suture Technique

    Double Suture Technique - classical SSF using two individual permanent sutures.

    Procedure: sacrospinous ligament fixation

  • Loop Suture Technique

    Loop Suture Technique - SSF using a single loop-style suture

    Procedure: sacrospinous ligament fixation

Interventions

  • Proceduresacrospinous ligament fixation

    A longitudinal incision was made at the midline of the posterior vaginal wall, extending approximately 2-3 cm from the perineal body to the vaginal apex to form a tunnel. The incised vaginal epithelium was dissected from the underlying muscularis layer. Dissection was continued to the level of the ischial spine. The rectum was medialized to access the perirectal space. Upon palpating the ischial spine, the sacrospinous ligament was identified medial to it. Long retractors were placed over the ischial spine to protect the pudendal neurovascular structures. The bladder was retracted superiorly, and the rectum medially, for optimal visualization. Two separate or a loop 1-0 polypropylene suture(s) were placed approximately 1.5 fingerbreadths medial to the ischial spine on the ligament using a needle holder. These sutures were passed through the posterior vaginal tunnel to the apex and tied to secure the vaginal apex to the ligament

06

What researchers measure

Primary outcomes

  1. Reoperation rate

    Reoperation rate due to prolapse recurrence within 24 months

    Time frame: 24 months

Secondary outcomes

  1. Total operative time (in minutes)

    Time frame: up to 200 minutes

  2. Postoperative complications (e.g. gluteal pain, hematoma)

    Time frame: 24 months

  3. Prolapse recurrence rate (Stage ≥2 on POP-Q)

    Time frame: 24 months

07

Study locations

1 site
  • Zeynep Kamil Women and Children's Diseases Training and Research Hospital
    Istanbul, Türkiye 34668, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jan 2020 to primary completion in Jan 2023, 36 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 3, 2025
First posted
Aug 6, 2025
StartActual
Jan 1, 2020
Primary completionActual
Jan 1, 2023
CompletionActual
Jan 1, 2025
Last update
Aug 6, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 6, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07106866
Lead sponsor
Zeynep Kamil Maternity and Pediatric Research and Training Hospital
Responsible party
Ayse Betul Albayrak Denizli (MD, Zeynep Kamil Maternity and Pediatric Research and Training Hospital) — Principal investigator
First posted
Aug 6, 2025
Start date
Jan 1, 2020
Primary completion
Jan 1, 2023
Completion
Jan 1, 2025
Last update
Aug 6, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion